External HDR Supervision - Elaine S. Rogers

Keogh, J. (Supervisor)

Activity: Professional Development, Mentorship, Supervision and Other ActivitiesExternal HDR Supervision

Description

The ACCeRT Study Auckland’s Cancer Cachexia evaluating Resistance Training Study A randomised feasibility study of EPA and Cox-2 inhibitor (Celecoxib) versus EPA, Cox-2 inhibitor (Celecoxib), Progressive Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic participants

Additional information

_Cancer cachexia is a common problem in Non-Small Cell Lung Cancer (NSCLC). In cancer cachexia there is a significant loss of adipose tissue and skeletal muscle mass. There is a need to utilise a multi-targeted approach to decrease the inflammation process and stimulate the skeletal anabolic pathways with the use of progressive resistance training (PRT) and Essential Amino Acids (EAA).Methods_ ACCeRT is a randomised controlled feasibility, open-label study, investigating the acceptability, trends in efficacy and safety of a multi-targeted approach in end-stage NSCLCcachectic patients, over 20 weeks. Participants were randomised
Period2017
Held atUniversity of Auckland, New Zealand
Degree of RecognitionInternational